Expertise Summary
15+ years of international experience in Market Access, Pricing & Reimbursement, HEOR, and Health Policy. Extensive work across Europe, U.S., and Emerging Markets. Therapeutic area expertise in oncology, rare diseases, nephrology, and immunology. Strong track record in HTA strategy, payer negotiations, evidence generation planning, and successful reimbursement submissions.
⸻
Core Expertise
• Pricing & Reimbursement Strategy
• HTA Submissions & Payer Engagement
• HEOR & Evidence Generation (incl. RWE)
• Value Communication & Dossiers
• Policy Advisory & Access Environment
• Communication & Negotiation Training
Selected Achievements
• Led global HEOR function and drove strategy for nephrology & rare disease assets (CSL Vifor).
• Led successful launches outperforming forecasts in key markets.
• Advanced oncology access strategies and payer collaborations (Amgen, Roche).
• Secured reimbursement for Humira indications without price concessions and shaped biosimilar reimbursement pathway (AbbVie, Switzerland).
• Published 10+ peer-reviewed papers in HEOR and value demonstration.
